Citations

Showing 10 of 108104 citations.

Outcomes in patients with myelofibrosis and RBC-transfusion dependence in the phase III PERSIST-1 study of pacritinib vs. best available therapy.
Harrison, Claire , Egyed, Miklós , Szőke, Anita , Suvorov, Aleksandr , Perkins, Andrew C. , Mayer, Jiřı́ , Schouten, Harry C. , Tosi, Patrizia , Zhou, Huafeng, Nangalia, Jyoti , Ganly, Peter S. , Farber, Charles Michael , Zachée, Pierre , Scheid, Christof , Dean, James P. , Kiladjian, Jean‐Jacques , Vannucchi, Alessandro M. , Mead, Adam J. , Mesa, Ruben A. , Perkins, Andrew C

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7066-7066

10.1200/jco.2016.34.15_suppl.7066 Get It

Acute leukemia in pregnancy: A single institution experience.
Farhadfar, Nosha , Cerquozzi, Sonia , Michael, Hessenauer R., Letendre, Louis, Litzow, Mark R. , Patnaik, Mrinal M. , Tefferi, Ayalew , Gangat, Naseema , Hogan, William J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7040-7040

10.1200/jco.2016.34.15_suppl.7040 Get It

MC1463: Avatar-directed chemotherapy in platinum-resistant ovarian cancer.
Long, Beverly, Hou, Xiaonan , Becker, Marc A., VanBlaricom, Jamison L., Bradley, Evans, Hendrickson, Andrea E. Wahner , Oberg, Ann L. , Heinzen, Ethan P. , Camoriano, John , Colón‐Otero, Gerardo , Burton, Jill K., Kalli, Kimberly R., Foster, Nathan R. , Weroha, Saravut J., Maurer, Matthew J. , Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS5609-TPS5609

10.1200/jco.2016.34.15_suppl.tps5609 Get It

11C-Choline PET guided resection of thoracic metastases from prostatic adenocarcinoma.
Moser, Justin C. , Dronca, Roxana , Kwon, Eugene D., Cassivi, Stephen D. , Mansfield, Aaron S. , Quevedo, Fernando

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16528-e16528

10.1200/jco.2016.34.15_suppl.e16528 Get It

Predictors for survival after radium-223 (R223) treatment for castration-resistant metastatic prostate cancer.
Anderson, Eric, Wong, William W. , Mohammadi, Homan , Daniels, T.B., Tzou, Katherine S., Keole, Sameer R., Choo, Richard , Vora, Sujay A., Schild, Steven E. , Bryce, Alan H. , Ho, Thai H. , Quevedo, Fernando

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e16521-e16521

10.1200/jco.2016.34.15_suppl.e16521 Get It

Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin–paclitaxel (CP) ± bevacizumab (BEV): Results from GOG-0218.
Tritchler, David , Starr, Mark D. , Brady, John C. , Hurwitz, Herbert I. , Mannel, Robert S., Tewari, Krishnansu S. , Gray, Heidi J. , Boente, Matthew, Deng, Wei , Burger, Robert A. , Birrer, Michael J. , Secord, Angeles Alvarez , Liu, Yingmiao , Lankes, Heather A. , O’Malley, David M. , Bakkum‐Gamez, Jamie N. , Fujiwara, Keiichi , Deng, Wei, Nixon, Andrew B.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5521-5521

10.1200/jco.2016.34.15_suppl.5521 Get It

Association of androgen receptor variant 9 (AR-V9) mRNA expression levels in metastatic tissue with resistance to abiraterone acetate/prednisone (AA/P).
Sicotte, Hugues , Carlson, Rachel E. , Tan, Winston , Wu, Kevin J. , Eiken, Patrick W. , Jiménez, Rafael E. , Cernigliaro, Joseph G. , Costello, Brian A. , Pitot, Henry C., Moynihan, Timothy J. , Wang, Liewei , Kohli, Manish , Hillman, David W. , Wang, Liguo , Li, Ying , Quevedo, Fernando , Ho, Thai H. , Bryce, Alan H. , Dehm, Scott M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5036-5036

10.1200/jco.2016.34.15_suppl.5036 Get It

Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.
Galsky, Matt D., Dawson, Nancy A. , Srinivas, Sandy, Vaishampayan, Ulka N. , Drakaki, Alexandra , Powles, Thomas, Hoffman‐Censits, Jean , Cui, Na , Mariathasan, Sanjeev , Thastrom, Ann Christine, Abidoye, Oyewale O., Bajorin, Dean F. , Vaishampayan, Ulka , Balar, Arjun Vasant , Loriot, Yohann , Necchi, Andrea , Joseph, Richard W. , Sridhar, Srikala S , Quinn, David I , Drakaki, Alexandra , Durán, Ignacio , Rosenberg, Jonathan E , Powles, Thomas

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: LBA4500-LBA4500

10.1200/jco.2016.34.15_suppl.lba4500 Get It

Inhibition of pancreatic cancer by targeting the epigenetic EZH2 complex.
Lomberk, Gwen , Missfeldt, Mckenna, Salmonson, Ann, Kossak, Sarah, Buttar, Navtej , Lomberk, Gwen L , Mathison, Angela , Urrutia, Raúl

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15736-e15736

10.1200/jco.2016.34.15_suppl.e15736 Get It